To succeed in China's dynamic pharmaceutical landscape, you must first have a good understanding of the China National Medical Products Administration (NMPA), how China regulates drugs, and China's pharmaceutical Good Manufacturing Practices (GMP) regulations. Speaker: Andrew Chen, J.D. Chief Representative, Shanghai Office of Arnold &...
Date: Thursday | March 28, 2024 Time: 12 noon to 1pm PT Location: Zoom Registration: Free for OCRA-DG members; $20 for nonmembers Artificial intelligence (AI) and machine learning (ML) technologies have the potential to advance drug development in multiple areas, including candidate identification and refinement,...